Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10
- 26 July 2010
- Vol. 28 (33) , 5467-5472
- https://doi.org/10.1016/j.vaccine.2010.05.066
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Controversies in Vaccine MandatesCurrent Problems in Pediatric and Adolescent Health Care, 2010
- Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary studyVaccine, 2010
- Vaccination, squalene and anti-squalene antibodies: Facts or fiction?European Journal of Internal Medicine, 2009
- Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesPublished by Elsevier ,2009
- What Should an Ideal Vaccine Postlicensure Safety System Be?American Journal of Public Health, 2009
- Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: A phase III study in a large population of Asian adultsVaccine, 2009
- Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical dataExpert Opinion on Biological Therapy, 2009
- Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoringVaccine, 2009
- Vaccines and Guillain-Barré SyndromeDrug Safety, 2009
- Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]BioDrugs, 2008